Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Altman

Showing results (501-510 of 514) with videos related to

Pageof 52
Sort By:
Plos One|November 14, 2013
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizesElijah R Behr, Marylyn D Ritchie, Toshihiro Tanaka, et al.
Clinical Pharmacology and Therapeutics|April 12, 2017
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug PrescribingP H O'Donnell, N Wadhwa, K Danahey, et al.
Lancet (London, England)|May 4, 2010
Clinical assessment incorporating a personal genomeEuan A Ashley, Atul J Butte, Matthew T Wheeler, et al.
Frontiers in Psychiatry|March 22, 2018
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive DisorderAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Plos Genetics|September 22, 2011
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceFrederick E Dewey, Rong Chen, Sergio P Cordero, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 6, 2019
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depressionAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Cell|March 20, 2012
Personal omics profiling reveals dynamic molecular and medical phenotypesRui Chen, George I Mias, Jennifer Li-Pook-Than, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Lancet (London, England)|June 13, 2013
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyMinoli A Perera, Larisa H Cavallari, Nita A Limdi, et al.
Human Mutation|June 22, 2017
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challengesRoxana Daneshjou, Yanran Wang, Yana Bromberg, et al.
Pageof 52

Showing results (501-510 of 514) with videos related to

Sort By:
Pageof 52
Plos One|November 14, 2013
Genome wide analysis of drug-induced torsades de pointes: lack of common variants with large effect sizesElijah R Behr, Marylyn D Ritchie, Toshihiro Tanaka, et al.
Clinical Pharmacology and Therapeutics|April 12, 2017
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug PrescribingP H O'Donnell, N Wadhwa, K Danahey, et al.
Lancet (London, England)|May 4, 2010
Clinical assessment incorporating a personal genomeEuan A Ashley, Atul J Butte, Matthew T Wheeler, et al.
Frontiers in Psychiatry|March 22, 2018
Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive DisorderAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Plos Genetics|September 22, 2011
Phased whole-genome genetic risk in a family quartet using a major allele reference sequenceFrederick E Dewey, Rong Chen, Sergio P Cordero, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 6, 2019
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depressionAzmeraw T Amare, Klaus Oliver Schubert, Fasil Tekola-Ayele, et al.
Cell|March 20, 2012
Personal omics profiling reveals dynamic molecular and medical phenotypesRui Chen, George I Mias, Jennifer Li-Pook-Than, et al.
Clinical Pharmacology and Therapeutics|November 8, 2012
Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysisE Danese, M Montagnana, J A Johnson, et al.
Lancet (London, England)|June 13, 2013
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association studyMinoli A Perera, Larisa H Cavallari, Nita A Limdi, et al.
Human Mutation|June 22, 2017
Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challengesRoxana Daneshjou, Yanran Wang, Yana Bromberg, et al.
Pageof 52